HIV Medicine

Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women
pp. 421-430(10)
Authors: Floris-Moore, M; Howard, AA; Lo, Y; Arnsten, JH; Santoro, N; Schoenbaum, EE

Long-term assessment of nevirapine-containing highly active antiretroviral therapy in antiretroviral-naive HIV-infected patients: 3-year follow-up of the VIRGO study
pp. 431-436(6)
Authors: Reliquet, V; Allavena, C; François-Brunet, C; Perré, P; Bellein, V; Garré, M; May, T; Souala, F; Besnier, J-M; Raffi, F

Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapy
pp. 437-441(5)
Authors: Sungkanuparph, S; Groger, RK; Overton, ET; Fraser, VJ; Powderly, WG

Resistance development over 144 weeks in treatment-naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903
pp. 442-450(9)
Authors: Margot, NA; Lu, B; Cheng, A; Miller, MD

Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy
pp. 451-456(6)
Authors: Buchacz, K; Brooks, JT; Tong, T; Moorman, AC; Baker, RK; Holmberg, SD; Greenberg, A

Longitudinal assessment (1995-2003) of hospitalizations of HIV-infected patients within a geographical population in Canada
pp. 457-466(10)
Authors: Krentz, HB; Dean, S; Gill, MJ

Prevalence of protective antibody against measles in HIV-infected children with immune recovery after highly active antiretroviral therapy
pp. 467-470(4)
Authors: Aurpibul, L; Puthanakit, T; Siriaksorn, S; Sirisanthana, T; Sirisanthana, V

Serum prostate-specific antigen levels in older men with or at risk of HIV infection
pp. 471-476(6)
Authors: Vianna, LE; Lo, Y; Klein, RS

Transmitted drug-resistant HIV-1 in primary HIV-1 infection; incidence, evolution and impact on response to antiretroviral therapy
pp. 477-483(7)
Authors: Fox, J; Dustan, S; McClure, M; Weber, J; Fidler, S

Estimating renal function in patients on tenofovir disoproxil fumarate: suggestions for safer use
pp. 484-485(2)
Authors: Winston, J; Shepp, DH

Re-audit of patients initiating antiretroviral therapy
pp. 486-486(1)
Authors: Curtis, H; Johnson, MA; Brook, G